Description
IGF::OT::IGF RADIUM-223 DICHLORIDE (XOFIGO)
First action · last action
2015-10-01 · 2016-10-07
Transactions
4
First transaction's obligation
$619,775
Base + all options value (sum of deltas)
$165,672
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA25114A0051
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2015-10-01+$619,775= $619,775
- Mod P000012016-07-25-$380,000= $239,775
- Mod P000022016-09-13-$50,000= $189,775
- Mod P000032016-10-07-$24,103= $165,672
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2015-10-01 | +$619,775 | $619,775 | IGF::OT::IGF RADIUM-223 DICHLORIDE (XOFIGO) |
| Mod P00001· FUNDING ONLY ACTION | 2016-07-25 | −$380,000 | $239,775 | IGF::OT::IGF RADIUM-223 DICHLORIDE (XOFIGO) |
| Mod P00002· FUNDING ONLY ACTION | 2016-09-13 | −$50,000 | $189,775 | IGF::OT::IGF RADIUM-223 DICHLORIDE (XOFIGO) |
| Mod P00003· FUNDING ONLY ACTION | 2016-10-07 | −$24,103 | $165,672 | IGF::OT::IGF RADIUM-223 DICHLORIDE (XOFIGO) |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI V1EVGCK7XES8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626N0492 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $386,860 | FY2026 |
| 36C26226F0163 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $181,386 | FY2026 |
| 36C26026F0086 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $80,663 | FY2026 |
| 36C26126N0199 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $101,567 | FY2026 |
| 36C25626N0126 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS | $214,783 | FY2026 |
| 36E79725A0028 | NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
Other recipients under 6505 from 583-INDIANAPOLIS(00583) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25018F0290 | ABBOTT LABORATORIES INC. | 583-INDIANAPOLIS(00583) | $13,793 | FY2018 |
| VA25017J4216 | PFIZER INC | 583-INDIANAPOLIS(00583) | $14,554 | FY2017 |
| VA25017F4218 | ALEXION PHARMACEUTICALS INC | 583-INDIANAPOLIS(00583) | $55,584 | FY2017 |
| VA25017J4118 | SHIRE US INC. | 583-INDIANAPOLIS(00583) | $41,697 | FY2017 |
| VA25017P3729 | MEDI-PHYSICS, INC. | 583-INDIANAPOLIS(00583) | $100,223 | FY2017 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25115J2170_3600_VA25114A0051_3600 · retrieved 2026-09-26.